Statistics from Altmetric.com
FOLLOWING the recent release of a novel medication for the management of idiopathic epilepsy in dogs, we are now in the rather fortunate position of being able to choose between two veterinary products licensed for the initiation of therapy. Both phenobarbital and imepitoin have been shown to be effective in dogs with idiopathic epilepsy and afford us the possibility to tailor our antiepileptic therapy specifically to the individual needs of a patient. In the past, if a dog demonstrated deleterious side effects on phenobarbital therapy, then there was not the option to change to a different veterinary product licensed as a sole therapy for idiopathic epilepsy …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.